President Donald Trump signed an executive order on Monday aimed at slashing prescription drug prices in the U.S. that could ...

As more doctors and patients turn to the latest weight-loss drugs, researchers are trying to figure out which drug is right ...

Hims & Hers offers rare high growth at value pricing, with DCF models pointing to major upside despite volatility and short ...

Tirzepatide (trade name Zepbound) promoted greater weight loss in individuals with obesity than did semaglutide (trade name Wegovy) in a clinical trial that compared the safety and efficacy of the ...

Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, ...

Participants who took tirzepatide — which is sold as Zepbound by Eli Lilly — lost an average of 50 pounds over 72 weeks.

The Trump plan won't be limited to Medicare prescriptions and will also target medications covered by Medicaid and private ...

Larger bodies gained visibility in recent years. One writer explores the limitations that are now running rampant within the fashion industry regarding plus-size brands and figures.

Sophia Umansky, Kyle Richards daughter, discusses losing 30 pounds on Mounjaro, addressing claims of body dysmorphia and her ...

Eli Lilly’s weight loss drug Zepbound led to significantly greater weight loss than Novo Nordisk’s Wegovy in a 72-week, head-to-head clinical trial, according to findings published in The New England ...

Nurse practitioner Amanda Hoelscher joined Good Day to share how popular weight loss drugs not only impact the numbers on the scale, but hormones as well.

Eventually, it was proven that Mounjaro is more affective than Wegovy in terms of weight loss, with 32 per cent of ...